Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · IEX Real-Time Price · USD

0.990

-0.005 (-0.52%)

At close: Jul 2, 2024, 4:00 PM

1.020

+0.030 (3.03%)

After-hours: Jul 2, 2024, 6:01 PM EDT

Oncolytics Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2000
Net Income	-27.75	-24.84	-26.3	-22.51	-33.12	Upgrade
Depreciation & Amortization	0.4	0.39	0.45	0.45	0.49	Upgrade
Share-Based Compensation	2.07	2.38	3.83	2.56	1.47	Upgrade
Other Operating Activities	-3.17	-1.29	-0.41	-2.57	11.26	Upgrade
Operating Cash Flow	-28.45	-23.36	-22.43	-22.07	-19.91	Upgrade
Capital Expenditures	-0.01	-0.06	-0.29	-0.03	-0.01	Upgrade
Change in Investments	20.23	-20.35	0	0	0	Upgrade
Investing Cash Flow	20.22	-20.4	-0.29	-0.03	-0.01	Upgrade
Share Issuance / Repurchase	31.62	12.57	33.14	39.99	21.46	Upgrade
Debt Issued / Paid	-0.41	-0.38	-0.37	-0.46	-0.45	Upgrade
Other Financing Activities	0.78	0.01	0.24	0.24	-	Upgrade
Financing Cash Flow	31.99	12.21	33.02	39.77	21.02	Upgrade
Exchange Rate Effect	-0.52	1.96	-0.25	-0.6	-0.65	Upgrade
Net Cash Flow	23.77	-31.55	10.3	17.68	1.1	Upgrade
Free Cash Flow	-28.46	-23.41	-22.72	-22.1	-19.92	Upgrade
Free Cash Flow Per Share	-0.42	-0.40	-0.42	-0.55	-0.90	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).